|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,834.05 INR | +5.67% |
|
+11.96% | +15.21% |
| 15/05 | Hester Biosciences Limited, Q4 2026 Earnings Call, May 15, 2026 | |
| 15/05 | Hester Biosciences' Consolidated Profit Soars in Fiscal Q4; Shares Jump 10% | MT |
| Capitalization | 1.07TCr 11Cr 9.63Cr 8.81Cr 8.4Cr 15Cr 16Cr 105.68Cr 41Cr 509.9Cr 42Cr 41Cr 1.78TCr | P/E ratio 2024 |
62.6x | P/E ratio 2025 | 38.8x |
|---|---|---|---|---|---|
| Enterprise value | 1.29TCr 13Cr 12Cr 11Cr 10Cr 19Cr 19Cr 126.97Cr 49Cr 612.62Cr 50Cr 49Cr 2.13TCr | EV / Sales 2024 |
4.53x | EV / Sales 2025 | 4.11x |
| Free-Float |
31.21% | Yield 2024 |
0.43% | Yield 2025 | 0.56% |
Last Transcript: Hester Biosciences Limited
| 1 day | +5.67% | ||
| 1 week | +11.96% | ||
| Current month | +11.95% | ||
| 1 month | +26.45% | ||
| 3 months | +17.57% | ||
| 6 months | +9.80% | ||
| Current year | +15.21% |
| 1 week | 1,629.9 |  | 1,997.95 |
| 1 month | 1,441.2 | | 1,997.95 |
| Current year | 1,250.95 | | 1,997.95 |
| 1 year | 1,250.95 | | 2,347.7 |
| 3 years | 1,246.75 | | 3,375.45 |
| 5 years | 1,246.75 | | 3,375.45 |
| 10 years | 608 | | 3,375.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 29/04/1987 | |
Ashish Desai
DFI | Director of Finance/CFO | - | 20/11/2025 |
Vinod Mali
CMP | Compliance Officer | - | 14/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | 21/04/2005 | |
| Director/Board Member | 63 | 29/04/1987 | |
| Director/Board Member | 61 | 29/04/1987 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.67% | +11.96% | +1.56% | +1.89% | 15Cr | |
| -1.67% | -14.99% | -52.09% | -59.58% | 3.16TCr | |
| -8.23% | -17.28% | +54.19% | +131.74% | 1.08TCr | |
| -3.10% | -3.33% | +21.88% | +49.69% | 571.46Cr | |
| +2.34% | -5.41% | +14.85% | +14.38% | 334.45Cr | |
| +7.14% | +0.87% | +111.57% | +32.63% | 225.47Cr | |
| -0.17% | -2.90% | -22.14% | -8.79% | 170.7Cr | |
| -4.92% | -20.37% | +47.13% | +144.63% | 146.64Cr | |
| -2.00% | -3.97% | -21.20% | -12.62% | 117.25Cr | |
| 0.00% | -1.91% | +3.30% | -47.90% | 108.36Cr | |
| Average | -0.49% | -5.72% | +15.90% | +24.61% | 593.49Cr | |
| Weighted average by Cap. | -2.44% | -10.35% | -10.55% | +1.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 311.19Cr 3.24Cr 2.79Cr 2.55Cr 2.43Cr 4.46Cr 4.54Cr 31Cr 12Cr 147.73Cr 12Cr 12Cr 514.68Cr | 312.47Cr 3.26Cr 2.8Cr 2.56Cr 2.44Cr 4.48Cr 4.56Cr 31Cr 12Cr 148.33Cr 12Cr 12Cr 516.79Cr |
| Net income | 19Cr 19.69L 16.94L 15.49L 14.78L 27.09L 27.54L 1.86Cr 71.91L 8.97Cr 73.89L 72.3L 31Cr | 27Cr 28.65L 24.65L 22.54L 21.51L 39.43L 40.08L 2.7Cr 1.05Cr 13Cr 1.08Cr 1.05Cr 45Cr |
| Net Debt | 229.07Cr 2.39Cr 2.05Cr 1.88Cr 1.79Cr 3.29Cr 3.34Cr 23Cr 8.72Cr 108.74Cr 8.96Cr 8.77Cr 378.86Cr | 216.39Cr 2.26Cr 1.94Cr 1.77Cr 1.69Cr 3.1Cr 3.16Cr 21Cr 8.24Cr 102.72Cr 8.46Cr 8.28Cr 357.88Cr |
Employees
562
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 1,834.05 ₹ | +5.67% | 6,025 |
| 14/26/14 | 1,735.65 ₹ | +1.58% | 484 |
| 13/26/13 | 1,708.65 ₹ | +0.77% | 396 |
| 12/26/12 | 1,695.55 ₹ | -2.51% | 1,151 |
| 11/26/11 | 1,739.15 ₹ | +5.43% | 515 |
Annual profits - Rate of surprise
- Stock Market
- Equities
- 524669 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition